The treatment of metastatic human and mouse melanoma cell lines with the anti-inflammatory phytochemical thymoquinone was shown to hamper the metastasis process by inhibition of the NLRP3 inflammasome [80]. This evidence concerns the gene NLRP3 and melanoma.